Feasibility trial of a pharmacist-led, personalised intervention targeting the incidence of reliever reliance and overuse in individuals with asthma.

Not Applicable

• Conditions: asthma; Respiratory - Asthma

• Registration Number: ACTRN12620001345976
• Lead Sponsor: Dr Amy Chan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-12-14
• Last Update Posted: 12 April 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Individuals presenting to one of the two enrolled community pharmacies will be eligible to participate in the study if they meet the following eligibility criteria:
-Aged 18 years or over
-Prescribed a short acting beta agonist (SABA) as a ‘reliever’ for their asthma symptoms.

Exclusion Criteria

Individuals will not be eligible to participate if they are using a SABA for a reason other than asthma (e.g. viral respiratory infection, exercise-induced asthma), do not manage their own medicines or anticipate changes to their medicines within the next 90 days (i.e. are following a step up/down medication management approach).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recruitment and retention rates of participants in control and intervention groups. Recruitment and retention rates will be estimated through recording the number of participants invited to participate in the intervention by the pharmacist, number of participants who view the study URL but do not enter the study, number of participants recruited online and via the pharmacist and number of participants retained at the 30 days and 90 days follow-up. Reasons for exclusion will also be recorded. These outcomes will be analysed by accessing the survey website analytics. [90 days post-intervention];The appropriateness of the outcome measures pre- and post-intervention which will be assessed by the number of completed questionnaires and proportion of participants with complete inhaler dispensing data.[90 days post-intervention];Degree of participant acceptability of the intervention, measured using a study specific questionnaire and incorporating time to complete questionnaires.[immediately after the intervention]

Secondary Outcome Measures

Name	Time	Method
Degree of pharmacist acceptability of the intervention measured using a study specific questionnaire and semi-structured interviews and incorporating time to provide intervention.[Completion of study recruitment (after last intervention patient is enrolled)];Changes in beliefs about SABA, measured by the SRQ[immediately after the intervention and at 30 and 90 days post-intervention];Changes in dispensing rates in SABA use measured using data-linkage to pharmacy dispensing records.[90 days post-intervention];Self-reported asthma-related GP visits between the intervention and control group in participants deemed high-risk of SABA overreliance measured using self-report on study-specific questionnaire[30 and 90 days post-intervention]